Lumonus
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $19M
Investors
- 4
About Lumonus
Based in Australia, Lumonus Pty Ltd specializes in providing intelligent software solutions for healthcare, enhancing care delivery in oncology and radiation therapy through innovative technology. Lumonus Pty Ltd is focused on developing advanced software solutions for healthcare. The founder's details are not disclosed, and there are no mentions of subsidiaries or significant business pivots. Lumonus AI specializes in providing intelligent software solutions that integrate seamlessly with existing healthcare systems. Their core product, Lumonus AI, functions as a smart assistant designed to enhance care delivery, particularly in oncology and radiation therapy. By streamlining processes such as patient dosimetry, Lumonus AI enables healthcare teams to significantly reduce turnaround times from planning to execution, allowing for more efficient care and improved patient outcomes. The company serves a diverse clientele, including healthcare providers such as hospitals and oncology centers, with notable customers including UMass Chan Medical School and Tacoma Radiation Oncology Centers.The revenue structure for Lumonus revolves around partnerships and business-to-business transactions, focusing on collaboration with healthcare institutions rather than direct consumer sales. Clients typically engage with Lumonus through subscription-based models or service agreements, which allow for ongoing access to their intelligent software solutions. For instance, healthcare providers may sign contracts that encompass comprehensive service bundles, ensuring they receive continuous software updates and support. The pricing plans for these services are structured to reflect the complexity and scale of the healthcare provider's needs, catering specifically to institutions requiring high-quality oncology solutions.Lumonus Pty Ltd is planning to innovate further with the development of new products aimed at enhancing their software solutions. The company is targeting market expansion into additional healthcare sectors in Australia and the United States by the end of the next fiscal year.
Who invested in Lumonus
4 investors across 2 rounds
See all investors in Lumonus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lumonus
Who invested in Lumonus?
Lumonus has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lumonus raised?
Lumonus has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lumonus last raise money?
Lumonus's most recent round on record is a Series B, in Mar 2026.
What does Lumonus do?
Based in Australia, Lumonus Pty Ltd specializes in providing intelligent software solutions for healthcare, enhancing care delivery in oncology and radiation therapy through innovative technology.
Where is Lumonus headquartered?
Lumonus is headquartered in Sydney, Australia.
Which VCs invest in companies like Lumonus?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Movac back healthcare specialists companies at Lumonus's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Lumonus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.